Nepafenac
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Nepafenac is used to treat eye pain, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 19, 2005. In 2024, Medicare Part D spent $17 million on Nepafenac across 41,000 claims for 22,000 beneficiaries.
Nepafenac is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $104.67 to $121.18 per ML — a 16% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$104.67 – $121.18
per ML
7d Activity
avg -0.1% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing NEPAFENAC
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ILEVRO 0.3% OPHTH DROPS | $121.1834 per ML | 0.00% |
NEVANAC 0.1% EYE DROP | $104.6692 per ML | -0.10% |
Frequently Asked Questions
What is Nepafenac used to treat?
Nepafenac is used to treat eye pain, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Nepafenac?
In 2024, Medicare Part D spent $17 million on Nepafenac across 41,000 claims for 22,000 beneficiaries.
How many Nepafenac products are on the market?
The Nepafenac drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Nepafenac?
NADAC reference prices for Nepafenac range from $104.6692 to $121.1834 per ML — a 16% difference between cheapest and most expensive.
Which manufacturers make Nepafenac?
1 manufacturer lists Nepafenac in NADAC. Ranked by number of NDCs, the largest are Harrow Eye, LLC (2).
How has the price of Nepafenac changed recently?
Over the past 7 days, 0 Nepafenac NDCs rose and 1 fell, with a market-wide average change of -0.1%.